[Form 4] Alumis Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Goldstein David M
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 107,950 | $0.00 | -- |
| Grant/Award | Common Stock | 27,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 107,950 shares (Direct);
Common Stock — 29,115 shares (Direct);
Common Stock — 207,903 shares (Indirect, By Trust)
Footnotes (1)
- Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant. 25% of the shares underlying this RSU vest on August 1, 2026, and the remaining shares vest in equal quarterly installments thereafter over the following 12 quarters, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date. Includes 2,115 shares acquired on May 20, 2025 under the Issuer's 2024 Employee Stock Purchase Plan. Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee. Shares are held directly by family members of Reporting Person residing in his primary residence. Shares are held directly by the Jacqueline Goldstein Trust dated September 17, 2019, for which the Reporting Person serves as trustee. Reporting Person became trustee on March 26, 2025 in a transaction that was exempt from reporting. 25% of the shares underlying this option vest on July 29, 2026, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan) to the Issuer on each such vesting date.
